Primary percutaneous coronary intervention in 'early' latecomers with ST-segment elevation acute myocardial infarction: The role of the infarct-related artery status

Journal of Cardiovascular Medicine

Volumn 12, Issue 1, 2011, Pages 13-18

  Fontanelli, Alessandro ^a   Bonanno, Carlo ^a  

^a SAN BORTOLO HOSPITAL   (Italy)

Author keywords

Early' latecomers; Infarct related artery status; Percutaneous coronary intervention; STEMI

Indexed keywords

STREPTOKINASE;

ACUTE HEART INFARCTION; ANGIOCARDIOGRAPHY; ELECTROCARDIOGRAM; FIBRINOLYTIC THERAPY; HEART INFARCTION SIZE; HEART MUSCLE REPERFUSION; HUMAN; PERCUTANEOUS CORONARY INTERVENTION; PRACTICE GUIDELINE; REVIEW; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; TREATMENT OUTCOME; VASCULAR PATENCY;

ANGIOPLASTY; CORONARY ARTERY DISEASE; ELECTROCARDIOGRAPHY; FIBRINOLYTIC AGENTS; HEART; HUMANS; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION; PRACTICE GUIDELINES AS TOPIC; THROMBOLYTIC THERAPY; TIME FACTORS; TREATMENT OUTCOME;

EID: 79953732317     PISSN: 15582027     EISSN: None     Source Type: Journal    
DOI: 10.2459/JCM.0b013e32834038d8     Document Type: Review

References (37)

1. Van de Werf F, Bax J, Betriu A, Blomstrom-Lundqvist C, Crea F, Falk V, et al. Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology. Eur Heart J 2008; 29:2909-2945.
2. Kushner FG, Hand M, Smith SC Jr, King SB 3rd, Anderson JL, Antman EM, et al., American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. 2009 focused updates: ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction (updating the 2004 guideline and 2007 focused update) and ACC/AHA/SCAI guidelines on percutaneous coronary intervention (updating the 2005 guideline and 2007 focused update): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 2009; 120:2271-2306.
3. Eagle KA, Goodman SG, Avezum A, Budaj A, Sullivan CM, Lopez-Sendon J. Practice variation and missed opportunities for reperfusion in ST-segment-elevation myocardial infarction: findings from the Global Registry of Acute Coronary Events (GRACE). Lancet 2002; 359:373-377. (Pubitemid 34158943)
4. Cohen M, Gensini GF, Maritz F, Gurfinkel EP, Huber K, Timerman A, et al. Prospective evaluation of clinical outcomes after acute ST-elevation myocardial infarction in patients who are ineligible for reperfusion therapy: preliminary results from the TETAMI registry and randomized trial. Circulation 2003; 108:III14-III21.
5. Di Pede F, Olivari Z, Schievano E, Spolaore P, Cacciavillani L, La Vecchia L, et al. Impact of reperfusion strategies on in-hospital outcome in ST-elevation myocardial infarction in a context of interhospital network: data from the prospective VENERE registry (VENEto acute myocardial infarction REgistry). Ital Heart J Suppl 2005; 6:804-811. (Pubitemid 44898628)
6. Agenzia Sanitaria e Sociale Regionale dell'Emilia-Romagna. REAL: Registro REgionale AngiopLastiche Coronariche. Innovare la pratica clinica con ricerca, condivisione e responsabilità. Pensiero Scientifico Editore 2008. p. 128. ISBN: 978-88-490-0248-5.
7. Rivas F, Cobb FR, Bache RJ, Greenfield JC Jr. Relationship between blood flow to ischaemic regions and extent of myocardial infarction. Serial measurement of blood flow to ischaemic regions in dogs. Circ Res 1976; 38:439-447.
8. Kloner RA, Shook T, Antman EM, Cannon CP, Przyklenk K, Yoo K, et al. Prospective temporal analysis of the onset of preinfarction angina versus outcome: an ancillary study in TIMI-9B. Circulation 1998; 97:1042-1045.
9. Ndrepepa G, Kastrati A, Schwaiger M, Mehilli J, Markwardt C, Dibra A, et al. Relationship between residual blood flow in the infarct-related artery and scintigraphic infarct size, myocardial salvage, and functional recovery in patients with acute myocardial infarction. J Nucl Med 2005; 46:1782-1788. (Pubitemid 46196638)
10. Schömig A, Mehilli J, Antoniucci D, Ndrepepa G, Markwardt C, Di Pede F, et al. Beyond 12 h Reperfusion Alternative Evaluation (BRAVE-2) Trial Investigators. Mechanical reperfusion in patients with acute myocardial infarction presenting more than 12 h from symptom onset: a randomized controlled trial. JAMA 2005; 293:2865-2872.
11. Stone GW, Cox D, Garcia E, Brodie BR, Morice MC, Griffin J, et al. Normal flow (TIMI-3) before mechanical reperfusion therapy is an independent determinant of survival in acute myocardial infarction: analysis from the primary angioplasty in myocardial infarction trials. Circulation 2001; 104:636-641. (Pubitemid 32738515)
12. Sabia PJ, Powers ER, Jayaweera AR, Ragosta M, Kaul S. Functional significance of collateral blood flow in patients with recent acute myocardial infarction. A study using myocardial contrast echocardiography. Circulation 1992; 85:2080-2089.
13. Sabia PJ, Powers ER, Ragosta M, Sarembock U, Burwell LR, Kaul S. An association between collateral blood flow and myocardial viability in patients with recent myocardial infarction. N Engl J Med 1992; 327:1825-1831. (Pubitemid 23003072)
14. Cribier A, Korsatz L, Koning R, Rath P, Gamra H, Stix G, et al. Improved myocardial ischaemic response and enhanced collateral circulation with long repetitive coronary occlusion during angioplasty: a prospective study. J Am Coll Cardiol 1992; 20:578-586.
15. Sawyer DB, Loscalzo J. Myocardial hibernation: restorative or preterminal sleep? Circulation 2002; 105:1517-1519.
16. Harken DE, Black H, Dickson JF III, Wilson HE III. De-epicardialization: a simple effective surgical treatment for angina pectoris. Circulation 1955; 12:955-962.
17. Dae MW, O'Connell JW, Botvinick EH, Chin MC. Acute and chronic effects of transient myocardial ischemia on sympathetic nerve activity, density, and norepinephrine content. Cardiovasc Res 1995; 30:270-280.
18. Reimer KA, Lowe JE, Rasmussen MM, Jennings RB. The wavefront phenomenon of ischaemic cell death. 1. Myocardial infarct size vs duration of coronary occlusion in dogs. Circulation 1977; 56:786-794.
19. Chesebro JH, Knatterud G, Roberts R, Borer J, Cohen LS, Dalen J, et al. Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: a comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge. Circulation 1987; 76:142-154.
20. Collen D, Stassen JM, Verstraete M. Thrombolysis with human extrinsic (tissue-type) plasminogen activator in rabbits with experimental jugular vein thrombosis. Effect of molecular form and dose of activator, age of the thrombus, and route of administration. J Clin Invest 1983; 71:368-376. (Pubitemid 13137502)
21. Veen G, Meyer A, Verheugt FW, Werter CJ, de Swart H, Lie KI, et al. Culprit lesion morphology and stenosis severity in the prediction of reocclusion after coronary thrombolysis: angiographic results of the APRICOT study. Antithrombotics in the Prevention of Reocclusion in Coronary Thrombolysis. J Am Coll Cardiol 1993; 22:1755-1762. (Pubitemid 23359628)
22. Topol EJ, Califf RM, Vandormael M, Grines CL, George BS, Sanz ML, et al., for the Thrombolysis Angioplasty in Myocardial Infarction-6 Study Group. A randomized trial of late reperfusion therapy for acute myocardial infarction. Thrombolysis and Angioplasty in Myocardial Infarction-6 Study Group. Circulation 1992; 85:2090-2099.
23. Dzavik V, Beanlands DS, Davies RF, Leddy D, Marquis JF, Teo KK, et al. Effects of late percutaneous transluminal coronary angioplasty of an occluded infarct related coronary artery on left ventricular function in patients with a recent (<6 weeks) Q-wave acute myocardial infarction (Total Occlusion Post-Myocardial Infarction Intervention Study [TOMIIS]: a pilot study). Am J Cardiol 1994; 73:856-861.
24. Yousef ZR, Redwood SR, Bucknall CA, Sulke AN, Marber MS. Late intervention after anterior myocardial infarction: effects on left ventricular size, function, quality of life, and exercise tolerance: results of the Open Artery Trial (TOAT Study). J Am Coll Cardiol 2002; 40:869-876. (Pubitemid 34994979)
25. Steg PG, Thuaire C, Himbert D, Carrie D, Champagne S, Coisne D, et al., DECOPI Investigators. DECOPI (DEsobstruction COronaire en Post- Infarctus): a randomized multicentre trial of occluded artery angioplasty after acute myocardial infarction. Eur Heart J 2004; 25:2187-2194.
26. Hochman JS, Lamas GA, Buller CE, Dzavik V, Reynolds HR, Abramsky SJ, et al. Coronary intervention for persistent occlusion after myocardial infarction. N Engl J Med 2006; 355:2395-2407. (Pubitemid 44911017)
27. Sabatè M. Revascularization of the infarct-related artery: never too late to do well. J Am Coll Cardiol 2008; 51:965-967.
28. Abbate A, Biondi-Zoccai GG, Appleton DL, Erne P, Schoenenberger AW, Lipinski MJ, et al. Survival and cardiac remodeling benefits in patients undergoing late percutaneous coronary intervention of the infarct-related artery: evidence from a meta-analysis of randomized controlled trials. J Am Coll Cardiol 2008; 51:956-964.
29. Menon V, Pearte CA, Buller CE, Steg PG, Forman SA, White HD, et al. Lack of benefit from percutaneous intervention of persistently occluded infarct arteries after the acute phase of myocardial infarction is time independent: insights from Occluded Artery Trial. Eur Heart J 2009; 30:183-191.
30. Busk M, Kaltoft A, Nielsen SS, Bøttcher M, Rehling M, Thuesen L, et al. Infarct size and myocardial salvage after primary angioplasty in patients presenting with symptoms for <12 h vs. 12-72 h. Eur Heart J 2009; 30:1322-1330.
31. Raitt MH, Maynard C, Wagner GS, Cerqueira MD, Selvester RH, Weaver WD. Appearance of abnormal Q waves early in the course of acute myocardial infarction: implications for efficacy of thrombolytic therapy. J Am Coll Cardiol 1995; 25:1084-1088.
32. Wong CK, Gao W, Raffel OC, French JK, Stewart RA, White HD, HERO-2 Investigators. Initial Q waves accompanying ST-segment elevation at presentation of acute myocardial infarction and 30-day mortality in patients given streptokinase therapy: an analysis from HERO-2. Lancet 2006; 367:2061-2067.
33. Eskola MJ, Holmvang L, Nikus KC, Sclarovsky S, Tilsted HH, Huhtala H, et al. The electrocardiographic window of opportunity to treat vs. the different evolving stages of ST-elevation myocardial infarction: correlation with therapeutic approach, coronary anatomy, and outcome in the DANAMI-2 trial. Eur Heart J 2007; 28:2985-2991. (Pubitemid 350262255)
34. Atak R, Ileri M, Senen K, Turhan H, Erbay AR, Basar N, et al. Correlation between infarct-related coronary artery patency and predischarge electrocardiographic patterns in patients with first anterior myocardial infarction who received thrombolytic therapy. Heart Vessels 2004; 19:63-67. (Pubitemid 38489032)
35. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality major morbidity results from all randomised trials of more than 1000 patients. Fibrinolytic Therapy Trialists' (FTT) Collaborative Group. Lancet 1994; 343:311-322.
36. Widimsky P, Budesinsky T, Vorac D, Groch L, Zelizko M, Aschermann M, et al., 'PRAGUE' Study Group Investigators. Long distance transport for primary angioplasty vs immediate thrombolysis in acute myocardial infarction. Final results of the randomized national multicentre trial: PRAGUE-2. Eur Heart J 2003; 24:94-104.
37. Steg PG, Bonnefoy E, Chabaud S, Lapostolle F, Dubien PY, Cristofini P, et al., Comparison of Angioplasty Prehospital Thrombolysis In acute Myocardial infarction (CAPTIM) Investigators. Impact of time to treatment on mortality after prehospital fibrinolysis or primary angioplasty: data from the CAPTIM randomized clinical trial. Circulation 2003; 108:2851-2856.